Asia Pacific Cell Line Development Market is expected to reach US$ 2,828.53 million by 2027

Media and Reagent Segment Held Largest Share of Product in Asia Pacific Cell Line Development Market in 2019

According to The Insight Partners market research study of ‘Asia Pacific cell line development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by type, product, and application’ the Asia Pacific cell line development market is expected to reach US$ 2,828.53 million in 2027 from US$ 993.09 million in 2019. The market is estimated to grow with a CAGR of 14.1% from 2020-2027. The report provides trends prevailing in the Asia Pacific cell line development market and the factors driving market along with those that act as hindrances.

Based on product, the cell line development market is segmented into equipment, and media and reagent. The media and reagent segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period. The media and reagent segment's growth is fuelled as media and reagents are important part of the cell line development process. For instance, trypan blue dye is used to differentiate between live and dead cells. Trypan blue is not absorbed by healthy viable cells. Thus, making it easy to differentiate.

The growth of this market is estimated to grow owing to key driving factors such as the high growth in investments from the government in development of cell line and a rising development of the biotechnology sector. However, the market growth is likely to be hindered owing to the multiple challenges in the cell line development.

WuXi AppTec, Merck KGaA , and Lonza are among the leading companies operating in the Asia Pacific cell line development market. 

The report segments Asia Pacific Cell Line Development Market as Follows:

By Type

• Primary Cell Line
• Hybridomas
• Continuous Cell Lines
• Recombinant Cell Line

By Product

• Equipment
• Media & Reagent

By Application

• Drug Discovery
• Bioproduction
• Tissue Engineering

By Country

• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific